PMID: 9450803Feb 5, 1998Paper

Mitoxantrone, a topoisomerase II inhibitor, induces apoptosis of B-chronic lymphocytic leukaemia cells

British Journal of Haematology
B BellosilloJ Gil

Abstract

B-chronic lymphocytic leukaemia (B-CLL) is characterized by the accumulation of long-lived CD5+ B lymphocytes. The effect of mitoxantrone, a topoisomerase II inhibitor, on B-CLL cells was studied. Treatment of B-CLL cells for 48 h with mitoxantrone (0.5 microg/ml) induced a decrease in cell viability as determined by MTT assay. The IC50 calculated for the cells of three patients was 0.7 microg/ml for two of them and 1.4 microg/ml for the third. In all three patients the maximum effect was observed with 2 microg/ml. An additive cytotoxic effect was observed when mitoxantrone (0.5 microg/ml) was combined with fludarabine (5 microg/ml). Mitoxantrone induced DNA fragmentation and the proteolytic cleavage of poly(ADP-ribose) polymerase (PARP), a marker of the activation of caspases, in all the patients studied, demonstrating that the cytotoxic effect of mitoxantrone was due to induction of apoptosis. These results suggest that mitoxantrone, and possibly other topoisomerase II inhibitors, may be used in the chemotherapy of B-CLL, and that combination of mitoxantrone with fludarabine or other drugs could improve the effectiveness of the treatment.

References

Jan 1, 1991·Advances in Experimental Medicine and Biology·C J CarreraD A Carson
Apr 1, 1990·British Journal of Haematology·A J Veerman, R Pieters
Oct 1, 1990·Annals of Internal Medicine·K A FoonR P Gale
Jan 1, 1989·Annual Review of Biochemistry·L F Liu
Dec 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·T D ChungC K Mirabelli
Jan 1, 1989·British Journal of Haematology·P R TwentymanJ K Rees
Jan 1, 1980·International Review of Cytology·A H WyllieA R Currie
Mar 1, 1995·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E Montserrat, C Rozman
Oct 19, 1995·The New England Journal of Medicine·C Rozman, E Montserrat
Apr 1, 1994·Current Opinion in Immunology·P H KrammerK M Debatin
Apr 1, 1993·Cancer Treatment Reviews·D Hochhauser, A L Harris
Mar 1, 1997·British Journal of Haematology·S L McKenna, R A Padua

❮ Previous
Next ❯

Citations

Oct 9, 2007·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Oliver NeuhausHans-Peter Hartung
Dec 11, 2002·British Journal of Haematology·Francesc BoschUNKNOWN GELCAB (Grup per l'Estudi dels Limfomes a Catalunya i Balears)
Jun 2, 2007·Biological & Pharmaceutical Bulletin·Xiao-Dong WangJian-Yong Wu
Feb 23, 2011·Therapeutics and Clinical Risk Management·Jeffrey Bryan, Gautam Borthakur
Nov 28, 2013·Scientifica·Alireza Minagar
Dec 21, 2004·Clinical and Experimental Immunology·A ChanR Gold
Dec 29, 2004·Leukemia & Lymphoma·Małgorzata RogalińskaZofia M Kiliańska
Aug 20, 2015·Medicinal Research Reviews·Benny J EvisonSuzanne M Cutts
Jan 23, 2016·International Journal of Biological Macromolecules·Anand Babu VelappanJoy Debnath
Oct 4, 2011·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Alex KiralyAnthony Quinn
Apr 7, 2010·Clinical Neurology and Neurosurgery·Reza Vosoughi, Mark S Freedman
Mar 30, 2007·Journal of the Neurological Sciences·Oliver NeuhausHans-Peter Hartung
Sep 3, 2003·Xenotransplantation·Thomas PetzoldGilles Blancho
Aug 14, 2012·Acta Neurologica Scandinavica·A Jamroz-WisniewskaH Bartosik-Psujek
Jul 21, 2004·Journal of the Neurological Sciences·Gilles EdanEmmanuelle Le Page
Jul 21, 2004·Journal of the Neurological Sciences·Oliver NeuhausHans-Peter Hartung
Apr 29, 2006·Journal of Neuroimmunology·Clara M PelfreyRobert J Fox
Aug 27, 2005·Journal of Neuroimmunology·Benedetta MazzantiFrancesco Lolli
Aug 13, 2005·Pharmacology & Therapeutics·Oliver NeuhausHans-Peter Hartung
Oct 7, 2014·Biochimica Et Biophysica Acta·Morgan A O'BrienPatrick F Forde
Aug 26, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Francesc BoschEmili Montserrat
Jun 9, 2005·Expert Review of Neurotherapeutics·Ee Tuan Lim, Gavin Giovannoni
Jun 6, 2007·Multiple Sclerosis : Clinical and Laboratory Research·M DebouverieH Vespignani
Apr 28, 2005·Expert Review of Neurotherapeutics·Oliver NeuhausHans-Peter Hartung
Jun 16, 2004·Cancer·Apostolia M TsimberidouSusan O'Brien
Jul 23, 2015·G3 : Genes - Genomes - Genetics·Irene Ojini, Alison Gammie
Jul 3, 2016·Cold Spring Harbor Protocols·Lisa C CrowleyNigel J Waterhouse
May 11, 1999·Hematological Oncology·C EmmanouilidesL Kunkel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.